Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|November 3, 2025
Increased autoantibodies against incretin indicate poor prognosis in patients with diabetesMinoru Takemoto, Bo-Shi Zhang, Aiko Hayashi, et al.Journal of Nephrology|December 23, 2016
Combination of cilostazol and probucol protected podocytes from lipopolysaccharide-induced injury by both anti-inflammatory and anti-oxidative mechanismsPeng He, Harukiyo Kawamura, Minoru Takemoto, et al.Journal of Diabetes Research|March 31, 2015
Pituitary adenylate cyclase-activating polypeptide protects glomerular podocytes from inflammatory injuriesKenichi Sakamoto, Kyoko Kuno, Minoru Takemoto, et al.Asia Pacific Journal of Clinical Nutrition|September 29, 2021
Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trialTakuya Minamizuka, Masaya Koshizaka, Mayumi Shoji, et al.Experimental Hematology|March 3, 2022
A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiencyHisaya Kato, Yoshiro Maezawa, Dai Nishijima, et al.Journal of Diabetes Investigation|July 6, 2020
Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study)Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, et al.Diabetes, Obesity & Metabolism|April 18, 2019
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study)Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, et al.Pageof 2